NCT00239174 - A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients | Biotech Hunter

Enrollment

394

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Obesity

Interventions

DRUG

SR147778

Trial Locations (5)

Sanofi-Aventis Administrative Office, Buenos Aires

sanofi-aventis Australia & New Zealand administrative office, Macquarie Park

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Barcelona